About Index Trending news
Analyze
Pricing
Rigontec GmbH

Rigontec GmbH

Work at Rigontec GmbH? Add yourself to this profile

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series A)
€15,000,000
Sunstone Capital, MP Healthcare Venture Management, NRW.BANK, +3
Employees

Unknown size

Locations
HQ
Headquarters
rigontec

Rigontec GmbH – A Dual Approach To Treat Cancer is a privately held biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases.

Health Science Funding
€15,000,000 Venture capital (Series A)
FinSMEs

Rigontec Raises €15M in Third Closing of Series A Funding

Funding Health